» Articles » PMID: 28499827

Drug-resistant Tuberculosis Threatens WHO's End-TB Strategy

Overview
Date 2017 May 14
PMID 28499827
Citations 10
Authors
Affiliations
Soon will be listed here.
Citing Articles

Global burden of multidrug-resistant tuberculosis in children and adolescents.

Zhong Y, Xie H, Cai F, Liu M, Gan H, Tang Z Pediatr Res. 2025; .

PMID: 39934644 DOI: 10.1038/s41390-025-03917-1.


Multidrug-Resistant Tuberculosis Treatment Outcome and Associated Factors at the University of Gondar Comprehensive Specialized Hospital: A Ten-Year Retrospective Study.

Belachew T, Yaheya S, Tilahun N, Gebrie E, Seid R, Nega T Infect Drug Resist. 2022; 15:2891-2899.

PMID: 35686191 PMC: 9172731. DOI: 10.2147/IDR.S365394.


Effects of secondary infections on the multidrug-resistant Tuberculosis: A cohort study.

Tabriz N, Nurtazina Z, Kozhamuratov M, Skak K, Mutaikhan Z Med J Islam Repub Iran. 2021; 35:105.

PMID: 34956951 PMC: 8683780. DOI: 10.47176/mjiri.35.105.


Trends in burden of multidrug-resistant tuberculosis in countries, regions, and worldwide from 1990 to 2017: results from the Global Burden of Disease study.

Ou Z, Yu D, Liang Y, He W, Li Y, Meng Y Infect Dis Poverty. 2021; 10(1):24.

PMID: 33676581 PMC: 7936417. DOI: 10.1186/s40249-021-00803-w.


Age-stratified anti-tuberculosis drug resistance profiles in South Korea: a multicenter retrospective study.

Lee E, Min J, Kang J, Kim S, Kim J, Kim Y BMC Infect Dis. 2020; 20(1):446.

PMID: 32576154 PMC: 7310538. DOI: 10.1186/s12879-020-05157-6.